In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...

Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be ...

Orbia Advance Corporation S.A.B. de C.V.’s Fluor & Energy Materials business announced its readiness to advance construction ...

Inhalers and nebulizers play a key role in delivering medication to the lungs, making it easier for people with breathing ...

Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and ...

The cold, dry air, reduced sunlight, and increased risks of respiratory infections combine to exacerbate symptoms for ...

Qnovia, Inc., a pharmaceutical company who recently announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for the RespiRxtm Nicotine ...

PORTLAND, OR, UNITED STATES, December 9, 2024 /EINPresswire / -- The global pulmonary drug delivery systems market is experiencing significant growth, driven by various factors including the rising ...

Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from ...

IT’S that time of year where we’re greeted by a cacophony of coughs, sneezes and sniffles wherever we go. You might think a cough is a cough, but different conditions will produce a ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from respiratory syncytial virus (RSV) in high-risk babies and young children - as ...